Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

472.50p
   
  • Change Today:
    -8.50p
  • 52 Week High: 1,225.00
  • 52 Week Low: 290.00
  • Currency: UK Pounds
  • Shares Issued: 101.70m
  • Volume: 48,425
  • Market Cap: £480.56m

Maxcyte (DI) Overview

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners’ challenges by applying our expertise.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -53.5% -48.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 17.1 13.3
Pr/Book 2.2  
Latest F'cast
Revenue 30.8% -12.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 13.98 (9.92) (20.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 16.67 (8.87) (17.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 21.62 (12.89) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 26.00 (11.82) (17.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 34.00 (19.08) (21.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 36.13 (17.59) (21.39)p n/a n/a n/a n/a 0.0%
31-Dec-23 45.75 (19.42) (21.89)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Second Quarter and Half-Year Results 11-Aug-2022 07:00 RNS
Filing of Form 10-Q for Second Quarter 11-Aug-2022 07:00 RNS
Total Voting Rights 02-Aug-2022 14:44 RNS

Maxcyte (DI) ShareCast News

MaxCyte hikes guidance after solid first half 11-Aug-2022 ShareCast
MaxCyte reports good first quarter revenue growth 10-May-2022 ShareCast
MaxCyte CFO resigns, first quarter revenues rise 13-Apr-2022 ShareCast

Latest Maxcyte (DI) Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 472.50p
Change Today -8.50p
% Change -1.77 %
52 Week High 1,225.00
52 Week Low 290.00
Volume 48,425
Shares Issued 101.70m
Market Cap £480.56m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 12-Aug-2022

Time Volume / Share Price
16:49 8,104 @ 471.25p
16:45 7,000 @ 482.00p
16:33 4,676 @ 471.25p
16:33 4,676 @ 471.25p
16:03 129 @ 479.02p

Top of Page